Published on 16 Nov 2022 on Zacks via Yahoo Finance
The Cooper Companies, Inc. COO is well-poised for growth, backed by strong prospects in both CooperVision (CVI) and CooperSurgical (CSI) business segments. The company’s acquisitions to complement its portfolio buoy optimism. However, unfavorable currency movements and rising costs continue to hurt the top line and margins, respectively.
Shares of the Zacks Rank #3 (Hold) company have lost 24.6% compared with the industry's decline of 16.4% so far this year. The S&P 500 Index has declined 18.2% in the same time frame.
Cooper Companies — with a market capitalization of $15.52 billion — is a specialty medical device company operating on a global basis. The company’s earnings are estimated to improve 11% over the next five years. The company missed earnings estimates in three of the trailing four quarters and beat once, the average negative surprise being 0.70%.